{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:15:31Z","timestamp":1791908131514,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/ijo.2009.238","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T11:15:04Z","timestamp":1259061304000},"page":"385-395","source":"Crossref","is-referenced-by-count":108,"title":["Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight"],"prefix":"10.1038","volume":"34","author":[{"given":"C M","family":"Mack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Athanacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V F","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Trevaskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gedulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Jodka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B L","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Herich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K D","family":"Laugero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"J R","family":"Paterniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,24]]},"reference":[{"key":"BFijo2009238_CR1","first-page":"1","volume-title":"Amylin: Physiology and Pharmacology","author":"A Young","year":"2005","unstructured":"Young A . Amylin: Physiology and Pharmacology. In: August JT, Murad F, Granner, D (eds). Amylin: Physiology and Pharmacology. Elsevier Academic Press: San Diego, CA, USA, 2005, pp 1\u201318."},{"key":"BFijo2009238_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00060793-199708000-00006","volume":"4","author":"AA Young","year":"1997","unstructured":"Young AA . Amylin's physiology and its role in diabetes. Curr Opin Endocrinol Diabetes 1997; 4: 282\u2013290.","journal-title":"Curr Opin Endocrinol Diabetes"},{"issue":"Suppl 2","key":"BFijo2009238_CR3","first-page":"865","volume":"45","author":"S Janes","year":"1996","unstructured":"Janes S, Gaeta L, Beaumont K, Beeley N, Rink T . The selection of pramlintide for clinical evaluation. Diabetes 1996; 45 (Suppl 2): 865 (abstract).","journal-title":"Diabetes"},{"key":"BFijo2009238_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","volume":"37","author":"AA Young","year":"1996","unstructured":"Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Gaeta L et al. Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Dev Res 1996; 37: 231\u2013248.","journal-title":"Drug Dev Res"},{"key":"BFijo2009238_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2174\/1381612013397357","volume":"7","author":"C Weyer","year":"2001","unstructured":"Weyer C, Maggs DG, Young AA, Kolterman OG . Amylin replacement with pramlintide as an adjunct in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr Pharm Des 2001; 7: 1353\u20131373.","journal-title":"Curr Pharm Des"},{"key":"BFijo2009238_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/VHRM.S1978","volume":"4","author":"BJ Hoogwerf","year":"2008","unstructured":"Hoogwerf BJ, Doshi KB, Diab D . Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected markers of vascular risk. Vasc Health Risk Manag 2008; 4: 355\u2013362.","journal-title":"Vasc Health Risk Manag"},{"key":"BFijo2009238_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/0063030-200822060-00004","volume":"22","author":"S Edelman","year":"2008","unstructured":"Edelman S, Maier H, Wilhelm K . Pramlintide in the treatment of diabetes mellitus. Biodrugs 2008; 22: 375\u2013386.","journal-title":"Biodrugs"},{"key":"BFijo2009238_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.physbeh.2006.04.001","volume":"89","author":"TA Lutz","year":"2006","unstructured":"Lutz TA . Amylinergic control of food intake. Physiol Behav 2006; 89: 465\u2013471.","journal-title":"Physiol Behav"},{"key":"BFijo2009238_CR9","first-page":"344","volume":"46","author":"PK Chelikani","year":"2006","unstructured":"Chelikani PK, Haver AC, Reidelberger RD . Relative potencies of anorexigenic substances in suppressing food intake in free feeding rats. Appetite 2006; 46: 344 (abstract).","journal-title":"Appetite"},{"key":"BFijo2009238_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","volume":"21","author":"TA Lutz","year":"2000","unstructured":"Lutz TA, Tschudy S, Rushing PA, Scharrer E . Amylin receptors mediate the anorectic action of salmon calcitonin. Peptides 2000; 21: 233\u2013238.","journal-title":"Peptides"},{"key":"BFijo2009238_CR11","doi-asserted-by":"publisher","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","volume":"293","author":"C Mack","year":"2007","unstructured":"Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss S et al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1855\u2013R1863.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2009238_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0091-3057(96)00168-2","volume":"56","author":"JE Morley","year":"1997","unstructured":"Morley JE, Suarez MD, Mattamal M, Flood JF . Amylin and food intake in mice: effects on motivation to eat and mechanism of action. Pharmacol Biochem Behav 1997; 56: 123\u2013129.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFijo2009238_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0196-9781(02)00022-0","volume":"23","author":"PA Rushing","year":"2002","unstructured":"Rushing PA, Seeley RJ, Air EL, Lutz TA, Woods SC . Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences. Peptides 2002; 23: 985\u2013988.","journal-title":"Peptides"},{"key":"BFijo2009238_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0196-9781(97)00292-1","volume":"19","author":"TA Lutz","year":"1998","unstructured":"Lutz TA, Senn M, Althaus J, Del Prete E, Ehrensperger F, Scharrer E . Lesion of the area postrema\/nucleus of the solitary tract (AP\/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 1998; 19: 309\u2013317.","journal-title":"Peptides"},{"key":"BFijo2009238_CR15","doi-asserted-by":"publisher","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","volume":"281","author":"T Riediger","year":"2001","unstructured":"Riediger T, Schmid HA, Lutz T, Simon E . Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1833\u2013R1843.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2009238_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","volume":"25","author":"TA Lutz","year":"2001","unstructured":"Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E . The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats. Int J Obes Relat Metab Disord 2001; 25: 1005\u20131011.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFijo2009238_CR17","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","volume":"286","author":"T Riediger","year":"2004","unstructured":"Riediger T, Zuend D, Becskei C, Lutz TA . The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut\u2013brain axis. Am J Physiol Regul Integr Comp Physiol 2004; 286: R114\u2013R122.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2009238_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0167-0115(97)01034-3","volume":"71","author":"NE Rowland","year":"1997","unstructured":"Rowland NE, Crews EC, Gentry RM . Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul Pept 1997; 71: 171\u2013174.","journal-title":"Regul Pept"},{"key":"BFijo2009238_CR19","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","volume":"142","author":"PA Rushing","year":"2001","unstructured":"Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL et al. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 2001; 142: 5035\u20135038.","journal-title":"Endocrinology"},{"key":"BFijo2009238_CR20","doi-asserted-by":"publisher","first-page":"R568","DOI":"10.1152\/ajpregu.00213.2004","volume":"287","author":"RD Reidelberger","year":"2004","unstructured":"Reidelberger RD, Haver AC, Arnelo U, Smith DD, Schaffert CS, Permert J . Amylin receptor blockade stimulates food intake in rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R568\u2013R574.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2009238_CR21","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1210\/en.2006-0393","volume":"147","author":"JD Roth","year":"2006","unstructured":"Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM . Antiobesity effects of the \u03b2-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 2006; 147: 5855\u20135864.","journal-title":"Endocrinology"},{"key":"BFijo2009238_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0031-9384(98)00110-3","volume":"64","author":"S Bhavsar","year":"1998","unstructured":"Bhavsar S, Watkins J, Young A . Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 1998; 64: 557\u2013561.","journal-title":"Physiol Behav"},{"key":"BFijo2009238_CR23","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1210\/en.2007-0898","volume":"148","author":"JD Roth","year":"2007","unstructured":"Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM et al. Combination therapy with amylin and peptide YY[3\u201336] in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology 2007; 148: 6054\u20136061.","journal-title":"Endocrinology"},{"key":"BFijo2009238_CR24","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1073\/pnas.0706473105","volume":"105","author":"JD Roth","year":"2008","unstructured":"Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 2008; 105: 7257\u20137262.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFijo2009238_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/ijo.2008.91","volume":"32","author":"JD Roth","year":"2008","unstructured":"Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C et al. Antiobesity effects of the \u03b2-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Int J Obes 2008; 32: 1201\u20131210.","journal-title":"Int J Obes"},{"key":"BFijo2009238_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/vhrm.2006.2.3.203","volume":"2","author":"J Pullman","year":"2006","unstructured":"Pullman J, Darsow T, Frias JP . Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes. Vasc Health Risk Manag 2006; 2: 203\u2013212.","journal-title":"Vasc Health Risk Manag"},{"key":"BFijo2009238_CR27","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1210\/jc.2006-2003","volume":"92","author":"L Aronne","year":"2007","unstructured":"Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC et al. Progressive reduction in body weight after treatment with the amylin analogue pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. J Clin Endocrinol Metab 2007; 92: 2977\u20132983.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009238_CR28","doi-asserted-by":"publisher","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","volume":"293","author":"SR Smith","year":"2007","unstructured":"Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC et al. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab 2007; 293: E620\u2013E627.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2009238_CR29","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2337\/dc08-0029","volume":"31","author":"SR Smith","year":"2008","unstructured":"Smith SR, Aronne LJ, Burns CM, Kesty NC, Halseth AE, Weyer C . Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care 2008; 31: 1816\u20131823.","journal-title":"Diabetes Care"},{"key":"BFijo2009238_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/187152208787169189","volume":"8","author":"JD Roth","year":"2008","unstructured":"Roth JD, Mack CM, Soares CJ, Ghosh SS, Parkes DG . Amylin-based pharmacotherapy-past, present and future. Immun Endoc Metab Agents in Med Chem 2008; 8: 317\u2013324.","journal-title":"Immun Endoc Metab Agents in Med Chem"},{"key":"BFijo2009238_CR31","first-page":"A181","volume":"15","author":"B Gedulin","year":"2007","unstructured":"Gedulin B, Smith P, Ghosh S, Young AA, Soares C, Parkes D et al. Prolonged duration of gastric emptying and plasma glucose reduction in rats treated with the amylinomimetic peptide AC2307. Obesity 2007; 15: A181\u2013A182 (abstract).","journal-title":"Obesity"},{"key":"BFijo2009238_CR32","unstructured":"Laugero KD, Mack C, Hanley M, Baron A, Parkes D . Rat amylin prevents stress-related feeding behavior. Soc Neurosci 2005; 530.17 (abstract)."},{"key":"BFijo2009238_CR33","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1113\/jphysiol.2002.018671","volume":"541","author":"S Eiden","year":"2002","unstructured":"Eiden S, Daniel C, Steinbrueck A, Schmidt I, Simon E . Salmon calcitonin\u2014a potent inhibitor of food intake in states of impaired leptin signaling on laboratory rodents. J Physiol 2002; 541: 1041\u20131048.","journal-title":"J Physiol"},{"key":"BFijo2009238_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1042\/BST0320865","volume":"32","author":"DL Hay","year":"2004","unstructured":"Hay DL, Christopoulus G, Christopoulus A, Sexton PM . Amylin receptors: molecular composition and pharmacology. Biochem Soc Trans 2004; 32: 865\u2013867.","journal-title":"Biochem Soc Trans"},{"key":"BFijo2009238_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1196\/annals.1317.076","volume":"1070","author":"PM Sexton","year":"2006","unstructured":"Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G et al. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs. Ann NY Acad Sci 2006; 1070: 90\u2013104.","journal-title":"Ann NY Acad Sci"},{"key":"BFijo2009238_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/eje.0.1330017","volume":"133","author":"R Muff","year":"1995","unstructured":"Muff R, Born W, Fischer JA . Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 1995; 133: 17\u201320.","journal-title":"Eur J Endocrinol"},{"key":"BFijo2009238_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3940(03)00190-3","volume":"341","author":"SW Barth","year":"2003","unstructured":"Barth SW, Riediger T, Lutz TA, Rechkemmer G . Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat. Neurosci Lett 2003; 341: 131\u2013134.","journal-title":"Neurosci Lett"},{"key":"BFijo2009238_CR38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","volume":"48","author":"I Chapman","year":"2005","unstructured":"Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Strobel S et al. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia 2005; 48: 838\u2013848.","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"BFijo2009238_CR39","first-page":"A433","volume":"57","author":"JPA Nicandro","year":"2008","unstructured":"Nicandro JPA, Ellero C, Pannacciulli N, Kesty NC, Deng W, Weyer C et al. AC2307, an amylin mimetic, reduced 24-h food intake in obese subjects (Abstract). Diabetes 2008; 57 (Suppl 1): A433 (abstract).","journal-title":"Diabetes"},{"key":"BFijo2009238_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/9781420051452-22","volume-title":"Handbook of Obesity","author":"JD Roth","year":"2008","unstructured":"Roth JD, Mack C, Parkes DG, Kesty NC, Weyer C . Integrated neurohormonal approach to the treatment of obesity: the amylin agonist pramlintide and its interactions with leptin and PYY signaling pathways. In: Bray GA, and Bouchard C (eds). Handbook of Obesity, 3rd edn. Informa Heathcare: New York, 2008. pp 341\u2013361."}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo2009238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2009238","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2009238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:21:16Z","timestamp":1684430476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2009238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,24]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFijo2009238"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2009.238","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,24]]}}}